USP Medicare Formulary Classes Should Use Mechanism Of Action, PhRMA Says

Subclasses should be based on other clinically relevant pharmacological characteristics, PhRMA tells USP pharmaceutical manufacturers forum. There should be enough classes to include the top 200 drugs for each of three Medicare subpopulations, PhRMA says.